Acute Cognitive Performance and Mood Effects of Coffeeberry Extract: A Randomized, Double Blind, Placebo-Controlled Crossover Study in Healthy Humans
Nutrients · 2023
DOI: 10.3390/nu15112418 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2023. Verfasst von Philippa A Jackson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brain Performance and Nutrition Research Centre, Northumbria University, Newcastle upon Tyne NE1 8ST, UK. Hauptthemen laut MEDLINE: Cognition, Beverages. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PepsiCo, PepsiCo, Purchase, NY, USA.
Abstract (Originalsprache)
Background
Coffeeberry extract, rich in chlorogenic acids, shows promise in improving mood and cognition, particularly when co-supplemented with phenolic compounds. However, limited work has considered the effects of coffeeberry in isolation, especially at low doses.
Objective
The current study investigated the effect of low and moderate doses of coffeeberry extract on cognition and mood.
Design
This randomized, double-blind, placebo-controlled crossover design investigated three active beverages on a sample of 72 healthy adults aged 18–49 years. The investigational beverages contained 100 mg or 300 mg coffeeberry extract (standardized to 40% chlorogenic acid), or 75 mg caffeine (positive control). Cognition, mood, and subjective energy were measured at baseline and then again at 60 and 120 min post-treatment.
Results
Analysis revealed no effect of 300 mg coffeeberry extract, while 100 mg resulted in increased mental fatigue during the performance of cognitively demanding tasks (p = 0.025) and decreased accuracy on a task of sustained attention (p = 0.003), compared to placebo, at 60 min post dose.
Conclusions
Administration of 100 mg and 300 mg coffeeberry extracts revealed limited, transient negative effects following 100 mg coffeeberry. Given the large number of outcome measures analysed and the absence of findings following the 300 mg dose, these negative findings should be interpreted with caution. Overall, the findings of the current study suggest that coffeeberry extract at a low or moderate dose does not have a beneficial effect on mood, mental and physical energy levels, or cognition; higher doses, as have been administered previously, may be more effective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain Performance and Nutrition Research Centre, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.
- Health Research Authority, Holland Drive, Newcastle upon Tyne NE2 4NQ, UK.
- PepsiCo, Health & Nutrition Sciences, Chicago, IL 60607, USA.
ORCID-Profile: Philippa A Jackson
Förderung
- PepsiCo
- PepsiCo, Purchase, NY, USA
Zitieren
APA
Jackson, P. A., Kenney, C., Forster, J., Smith, E. F., Elcoate, R., Spittlehouse, B., Johnson, J., & Kennedy, D. O. (2023). Acute Cognitive Performance and Mood Effects of Coffeeberry Extract: A Randomized, Double Blind, Placebo-Controlled Crossover Study in Healthy Humans. Nutrients. https://doi.org/10.3390/nu15112418
Vancouver
Jackson PA, Kenney C, Forster J, Smith EF, Elcoate R, Spittlehouse B, et al. Acute Cognitive Performance and Mood Effects of Coffeeberry Extract: A Randomized, Double Blind, Placebo-Controlled Crossover Study in Healthy Humans. Nutrients. 2023. doi:10.3390/nu15112418
BibTeX
@article{Jackson2023,
author = {Jackson, Philippa A and Kenney, Charlotte and Forster, Joanne and Smith, Ellen F and Elcoate, Rian and Spittlehouse, Bethany and Johnson, Jodee and Kennedy, David O},
title = {Acute Cognitive Performance and Mood Effects of Coffeeberry Extract: A Randomized, Double Blind, Placebo-Controlled Crossover Study in Healthy Humans},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15112418}
}
EUVIMED